DAIC

JUNE 24, 2024

milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. , Food and Drug Administration ( FDA ) of the company's Cordella Pulmonary Artery (PA) Sensor System for the treatment of New York Heart Failure (NYHA) class III heart failure patients.

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , The CMS coverage approval is supported by the scientific rigor of the protocol design and the results from the interim data from the CardiAMP Heart Failure Trial recently presented at the Technology and Heart Failure Therapeutics 2024 annual meeting.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MARCH 29, 2024

milla1cf Fri, 03/29/2024 - 08:08 March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology 's ( ACC ) Annual Scientific Session & Expo taking place April 6-8 in Atlanta. and worldwide," said Neal Eigler, M.D. , CEO of V-Wave. million people globally.

Preserved Ejection Fraction 111

Preserved Ejection Fraction Heart Failure Quality of Life Hospital 111

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52